Tandem Diabetes Expands Tandem Mobi Compatibility to Android Devices
Event summary
- Tandem Diabetes Care's Tandem Mobi automated insulin delivery system is now compatible with Android smartphones in the U.S.
- The Tandem Mobi mobile app received FDA clearance for Android compatibility in November 2025 and launched in limited release in December 2025
- Compatible Android devices include Google Pixel models 6 through 10 and Samsung Galaxy models S21 through S25
- Tandem Mobi is powered by Control-IQ+ technology, which has demonstrated benefits such as 79% time in range and 90% overnight time in range
The big picture
Tandem Diabetes Care's expansion of Tandem Mobi compatibility to Android devices underscores the company's commitment to broadening its reach in the diabetes technology market. This move aligns with broader industry trends towards greater device interoperability and user convenience, potentially setting a new standard for automated insulin delivery systems.
What we're watching
- Market Penetration
- How the expansion to Android will affect Tandem Diabetes Care's market share in the automated insulin delivery space.
- Regulatory Compliance
- Whether Tandem Diabetes Care can maintain compliance with FDA regulations as it continues to expand its product offerings.
- Competitive Dynamics
- The pace at which competitors like Medtronic and Insulet will respond with their own Android-compatible solutions.
Related topics